相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Implementation of TPMT testing
Lynne Lennard
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2014)
Intravenous Immunoglobulins: In-Depth Review of Excipients and Acute Kidney Injury Risk
Jacques Dantal
AMERICAN JOURNAL OF NEPHROLOGY (2013)
Diagnosis and therapy of myasthenia gravis with antibodies to muscle-specific kinase
Amelia Evoli et al.
AUTOIMMUNITY REVIEWS (2013)
Therapeutic plasma exchange: A technical and operational review
Andre A. Kaplan
JOURNAL OF CLINICAL APHERESIS (2013)
A Retrospective study of complications of therapeutic plasma exchange in myasthenia
Jeffrey T. Guptill et al.
MUSCLE & NERVE (2013)
PROLONGED B-CELL DEPLETION IN MuSK MYASTHENIA GRAVIS FOLLOWING RITUXIMAB TREATMENT
John S. Yi et al.
MUSCLE & NERVE (2013)
Safety of plasma exchange therapy in patients with myasthenia gravis
Hamid Ebadi et al.
MUSCLE & NERVE (2013)
Management of Juvenile Myasthenia Gravis
Cristian M. Ionita et al.
PEDIATRIC NEUROLOGY (2013)
Management challenges in muscle-specific tyrosine kinase myasthenia gravis
Amelia Evoli et al.
MYASTHENIA GRAVIS AND RELATED DISORDERS I (2012)
The role of anti-IgA antibodies in causing adverse reactions to gamma globulin infusion in immunodeficient patients: A comprehensive review of the literature
Rima Rachid et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2012)
The choice of vascular access for therapeutic apheresis
Kambiz Kalantari
JOURNAL OF CLINICAL APHERESIS (2012)
3,4-Diaminopyridine improves neuromuscular transmission in a MuSK antibody-induced mouse model of myasthenia gravis
Shuuichi Mori et al.
JOURNAL OF NEUROIMMUNOLOGY (2012)
Estimated cost of treating myasthenia gravis in an insured U.S. population
Jeffery T. Guptill et al.
MUSCLE & NERVE (2012)
Long-lasting treatment effect of rituximab in MuSK myasthenia
J. Diaz-Manera et al.
NEUROLOGY (2012)
Myasthenia Gravis
Nicholas J. Silvestri et al.
SEMINARS IN NEUROLOGY (2012)
Cost-minimization analysis of the direct costs of TPE and IVIg in the treatment of Guillain-Barre syndrome
Jeffrey L. Winters et al.
BMC HEALTH SERVICES RESEARCH (2011)
Use and monitoring of low dose rituximab in myasthenia gravis
Stefan Blum et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2011)
ANTI-MuSK ANTIBODY MYASTHENIA GRAVIS: CLINICAL FINDINGS AND RESPONSE TO TREATMENT IN TWO LARGE COHORTS
Jeffrey T. Guptill et al.
MUSCLE & NERVE (2011)
Comparative Analysis of Therapeutic Options Used for Myasthenia Gravis
Aditya Mandawat et al.
ANNALS OF NEUROLOGY (2010)
Immunosuppressive therapies in myasthenia gravis
Donald B. Sanders et al.
AUTOIMMUNITY (2010)
Identification and comparison of adverse events for preparations of IVIG in patients with neuromuscular diseases
Janel O. Nadeau et al.
CLINICAL NEUROLOGY AND NEUROSURGERY (2010)
Update on muscle-specific tyrosine kinase antibody positive myasthenia gravis
Jeffrey T. Guptill et al.
CURRENT OPINION IN NEUROLOGY (2010)
Guidelines for treatment of autoimmune neuromuscular transmission disorders
G. O. Skeie et al.
EUROPEAN JOURNAL OF NEUROLOGY (2010)
Progressive multifocal leukoencephalopathy and other disorders caused by JC virus: clinical features and pathogenesis
Chen S. Tan et al.
LANCET NEUROLOGY (2010)
MYCOPHENOLATE MOFETIL IN AChR-ANTIBODY-POSITIVE MYASTHENIA GRAVIS: OUTCOMES IN 102 PATIENTS
Michael K. Hehir et al.
MUSCLE & NERVE (2010)
CLINICAL FINDINGS IN MuSK-ANTIBODY POSITIVE MYASTHENIA GRAVIS: A US EXPERIENCE
Mamatha Pasnoor et al.
MUSCLE & NERVE (2010)
Muscle-Specific Receptor Tyrosine Kinase Antibody Positive Myasthenia Gravis Current Status
Shin Joong Oh
JOURNAL OF CLINICAL NEUROLOGY (2009)
ACETYLCHOLINESTERASE INHIBITORS IN MYASTHENIA GRAVIS: TO BE OR NOT TO BE?
Anna Rostedt Punga et al.
MUSCLE & NERVE (2009)
Lessons from two trials of mycophenolate mofetil in myasthenia gravis
Donald B. Sanders et al.
MYASTHENIA GRAVIS AND RELATED DISORDERS: 11TH INTERNATIONAL CONFERENCE (2008)
Tacrolimus for myasthenia gravis - A clinical study of 212 patients
Jose M. Ponseti et al.
MYASTHENIA GRAVIS AND RELATED DISORDERS: 11TH INTERNATIONAL CONFERENCE (2008)
Clinical phenotype of muscle-specific tyrosine kinase-antibody positive myasthenia gravis
Gil I. Wolfe et al.
MYASTHENIA GRAVIS AND RELATED DISORDERS: 11TH INTERNATIONAL CONFERENCE (2008)
Response to therapy in myasthenia gravis with anti-MuSK antibodies
Amelia Evoli et al.
MYASTHENIA GRAVIS AND RELATED DISORDERS: 11TH INTERNATIONAL CONFERENCE (2008)
Rebooting the immune system with high-dose cyclophosphamide for treatment of refractory myasthenia gravis
Daniel B. Drachman et al.
MYASTHENIA GRAVIS AND RELATED DISORDERS: 11TH INTERNATIONAL CONFERENCE (2008)
Myasthenia gravis seronegative for acetylcholine receptor antibodies
Angela Vincent et al.
MYASTHENIA GRAVIS AND RELATED DISORDERS: 11TH INTERNATIONAL CONFERENCE (2008)
EFNS guidelines for the use of intravenous immunoglobulin in treatment of neurological diseases
I. Elovaara et al.
EUROPEAN JOURNAL OF NEUROLOGY (2008)
MuSK-antibody positive myasthenia gravis: Questions from the clinic
Donald B. Sanders et al.
JOURNAL OF NEUROIMMUNOLOGY (2008)
A trial of mycophenolate mofetil with prednisone as initial immunotherapy in myasthenia gravis
NEUROLOGY (2008)
An international, phase III, randomized trial of mycophenolate mofetil in myasthenia gravis
D. B. Sanders et al.
NEUROLOGY (2008)
Progressive Multifocal Leukoencephalopathy and Use of Mycophenolate Mofetil After Kidney Transplantation
Robert T. Neff et al.
TRANSPLANTATION (2008)
Steroids and immunosuppressant drugs in myasthenia gravis
Sivakumar Sathasivam
NATURE CLINICAL PRACTICE NEUROLOGY (2008)
Post-thymectomy combined treatment of prednisone and tacrolimus versus prednisone alone for consolidation of complete stable remission in patients with myasthenia gravis:: a non-randomized, non-controlled study
José M. Ponseti et al.
CURRENT MEDICAL RESEARCH AND OPINION (2007)
Safety of intravenous immunoglobulin (IVIG) therapy
Uriel Katz et al.
AUTOIMMUNITY REVIEWS (2007)
Clinical comparison of anti-MuSK- vs anti-AChR-positive and seronegative myasthenia gravis
F. Deymeer et al.
NEUROLOGY (2007)
Anti-MuSK antibodies: Correlation with myasthenia gravis severity
E. Bartoccioni et al.
NEUROLOGY (2006)
Glucocorticoid modulation of cytokine signaling
I. Rogatsky et al.
TISSUE ANTIGENS (2006)
Neurophysiological and mitochondrial abnormalities in MuSK antibody seropositive myasthenia gravis compared to other immunological subtypes
A. Rostedt Punga et al.
CLINICAL NEUROPHYSIOLOGY (2006)
Cholinergic neuromuscular hyperactivity in patients with myasthenia gravis seropositive for musk antibody
Anna Rostedt Punga et al.
MUSCLE & NERVE (2006)
Successful treatment of musk antibody-positive myasthenia gravis with rituximab
B Hain et al.
MUSCLE & NERVE (2006)
Single-fiber electromyography in limb and facial muscles in muscle-specific kinase antibody and acetylcholine receptor antibody myasthenia gravis
ME Farrugia et al.
MUSCLE & NERVE (2006)
High-dose cyclophosphamide in refractory myasthenia gravis with MuSK antibodies
PT Lin et al.
MUSCLE & NERVE (2006)
Glucocorticoids in T cell apoptosis and function
MJ Herold et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2006)
Complications of therapeutic plasma exchange: Experience with 4857 treatments
N Basic-Jukic et al.
THERAPEUTIC APHERESIS AND DIALYSIS (2005)
Thymus changes in anti-MuSK-positive and -negative myasthenia gravis
E Saka et al.
NEUROLOGY (2005)
MuSK-antibody positive myasthenia gravis: Clinical and electrodiagnostic patterns
DE Stickler et al.
CLINICAL NEUROPHYSIOLOGY (2005)
Primary CNS lymphoma complicating treatment of myasthenia gravis with mycophenolate mofetil
S Vernino et al.
NEUROLOGY (2005)
The features of myasthenia gravis with autoantibodies to MuSK
D Lavrnic et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2005)
Long-term results of tacrolimus in cyclosporine- and prednisone-dependent myasthenia gravis
JM Ponseti et al.
NEUROLOGY (2005)
Benefits of FK506 (tacrolimus) for residual, cyclosporin- and prednisone-resistant myasthenia gravis: one-year follow-up of an open-label study
JA Ponseti et al.
CLINICAL NEUROLOGY AND NEUROSURGERY (2005)
Fewer thymic changes in MuSK antibody-positive than in MuSK antibody-negative MG
MI Leite et al.
ANNALS OF NEUROLOGY (2005)
Thymus changes in anti-MuSK-positive and -negative myasthenia gravis
L Lauriola et al.
NEUROLOGY (2005)
Corticosteroids for myasthenia gravis - art. no. CD002828.pub2
C Scheider-Gold et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2005)
Myasthenia gravis: Management of myasthenic crisis and perioperative care
VC Juel
SEMINARS IN NEUROLOGY (2004)
Thymectomy in the management of myasthenia gravis
A Jaretzki et al.
SEMINARS IN NEUROLOGY (2004)
Clinical comparison of muscle-specific tyrosine kinase (MuSK) antibody-positive and -negative myasthenic patients
L Zhou et al.
MUSCLE & NERVE (2004)
Treatment of autoimmune myasthenia gravis
DP Richman et al.
NEUROLOGY (2003)
Mycophenolate mofetil for myasthenia gravis - An analysis of efficacy, safety, and tolerability
MN Meriggioli et al.
NEUROLOGY (2003)
Clinical correlates with anti-MuSK antibodies in generalized seronegative myasthenia gravis
A Evoli et al.
BRAIN (2003)
Clinical aspects of MuSK antibody positive seronegative MG
DB Sanders et al.
NEUROLOGY (2003)
Treatment of refractory myasthenia: Rebooting with high-dose cyclophosphamide
DB Drachman et al.
ANNALS OF NEUROLOGY (2003)
Use of intravenous pulsed cyclophosphamide in severe, generalized myasthenia gravis
LG De Feo et al.
MUSCLE & NERVE (2002)
Auto-antibodies to the receptor tyrosine kinase MuSK in patients with myasthenia gravis without acetylcholine receptor antibodies
W Hoch et al.
NATURE MEDICINE (2001)
Mycophenolate mofetil: A safe and promising immunosuppressant in neuromuscular diseases
V Chaudhry et al.
NEUROLOGY (2001)
Mycophenolate mofetil for myasthenia gravis: An open-label pilot study
E Ciafaloni et al.
NEUROLOGY (2001)
Retrospective analysis of the use of cyclosporine in myasthenia gravis
E Ciafaloni et al.
NEUROLOGY (2000)
分享论文
